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Dickkopf-3 links HSF1 and YAP/TAZ signalling to
control aggressive behaviours in cancer-associated
ﬁbroblasts
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Aaron J. Farrugia1, Maxine Lam1, Maria Semiannikova1, Marie C. W. Westergaard5, Julia Tchou6,
Luca Magnani 2 & Fernando Calvo1,7
Aggressive behaviours of solid tumours are highly inﬂuenced by the tumour microenviron-
ment. Multiple signalling pathways can affect the normal function of stromal ﬁbroblasts in
tumours, but how these events are coordinated to generate tumour-promoting cancer-
associated ﬁbroblasts (CAFs) is not well understood. Here we show that stromal expression
of Dickkopf-3 (DKK3) is associated with aggressive breast, colorectal and ovarian cancers.
We demonstrate that DKK3 is a HSF1 effector that modulates the pro-tumorigenic behaviour
of CAFs in vitro and in vivo. DKK3 orchestrates a concomitant activation of β-catenin and
YAP/TAZ. Whereas β-catenin is dispensable for CAF-mediated ECM remodelling, cancer cell
growth and invasion, DKK3-driven YAP/TAZ activation is required to induce tumour-
promoting phenotypes. Mechanistically, DKK3 in CAFs acts via canonical Wnt signalling by
interfering with the negative regulator Kremen and increasing cell-surface levels of LRP6. This
work reveals an unpredicted link between HSF1, Wnt signalling and YAP/TAZ relevant for the
generation of tumour-promoting CAFs.
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Stepwise acquisition of genetic alterations is crucial for theinitiation of primary epithelial tumours. Yet, increasingevidence supports the notion that concomitant stromal
changes play a critical role in cancer progression in many types of
neoplasias1,2. Fibroblasts constitute a signiﬁcant proportion of the
stromal compartment in many solid tumours. As opposed to
normal ﬁbroblasts, which are generally anti-tumorigenic3, cancer-
associated ﬁbroblasts (CAFs) present a pathological activated
phenotype that enables them to inﬂuence tumour progression,
dissemination and response to therapy through remodelling of
the extracellular matrix (ECM) and signalling to cancer, endo-
thelial and immune cells4,5. In CAFs, signalling pathways such as
Heat-Shock Factor 1 (HSF1) and YAP/TAZ are activated in
response to cellular stress and mechanical cues, respectively6,7. In
turn, HSF1 affects signalling to cancer cells promoting tumour
growth whereas YAP promotes cancer cell invasion and angio-
genesis through remodelling of the ECM. Thus, each pathway is
regulated by different mechanisms and controls a deﬁned set of
functions; whether these molecular events are interconnected to
regulate the emergence of a fully activated CAF phenotype is not
known.
Dickkopf (DKK) proteins comprise a conserved family of
secreted negative regulators of β-catenin8. DKK1, DKK2 and
DKK4 have been shown to antagonise Wnt-mediated β-catenin
stabilisation by binding and down-modulating Wnt co-receptor
LRP5/69,10. In contrast, DKK3 does not interact with LRP5/6 and
thus is not considered a true Wnt signalling antagonist. The role
of DKK proteins in cancer is thought to be mainly tumour sup-
pressive, as they are commonly downregulated in cancer cells and
can negatively affect proliferation and survival. Yet, the role of
DKK proteins in cancer stroma is still understudied.
In this study we uncover an unprecedented role for DKK3 in
linking HSF1 and YAP/TAZ signalling. We demonstrate that
DKK3 is a HSF1 target gene that promotes aggressive behaviours
in CAFs by potentiating YAP/TAZ activity via canonical
Wnt signalling. Mechanistically, we show that DKK3 promotes
LRP5/6 activity by interfering with the negative Wnt regulator
Kremen1/2.
Results
DKK3 expression levels in the tumour microenvironment. The
initial evidence suggesting that DKK3 may play a role in the
regulation of the tumour microenvironment came from analyses
of stromal gene expression in normal and cancerous tissues
(Supplementary Figure 1a). DKK3 gene and protein expression is
signiﬁcantly upregulated in the tumour stroma in several types of
cancers including breast, colon and ovarian (Supplementary
Figure 1a and Fig. 1a–c). Stromal expression of other DKK genes
across various cancer types was less consistent (Supplementary
Figure 1a), suggesting that DKK3 is the only DKK factor com-
monly associated with cancer stroma. DKK3 protein levels in
breast cancer (BC) stroma were signiﬁcantly increased upon
progression to more aggressive cancers, particularly in ER-
negative BC (Fig. 1d and Supplementary Figure 1b). Furthermore,
in ER-negative BC there was a signiﬁcant association between
high stromal DKK3 gene expression and poor outcome (Fig. 1e).
Analysis of human BC tissues showed that stromal DKK3
expression was restricted to vimentin-positive cells (Fig. 1f), an
expression pattern characteristic of CAFs11,12. To investigate the
cell of origin of DKK3 expression, we isolated different cell
populations of murine MMTV-PyMT mammary carcinomas
(Supplementary Figure 1c&d, see Methods for details). Dkk3
expression was restricted to CAFs (Fig. 1g). Similar ﬁndings were
obtained in a human setting13 (Supplementary Figure 1e). Stro-
mal DKK3 expression in human tumours positively correlated
with the expression of CAF markers ACTA2, FAP and COL1A2
(Fig. 1h), supporting a link between DKK3 and CAFs. As DKK3
was restricted to CAFs in tumours, we investigated the prognostic
potential of whole tumour DKK3 expression. These analyses
indicated a signiﬁcant correlation between DKK3 gene expression
and poor outcome in ER-negative BC patients, as well as in colon
and ovarian cancer patients (Fig. 1i).
DKK3 is a HSF1 target gene upregulated in CAFs. To investi-
gate DKK3 in tractable models, we isolated CAFs from murine
mammary carcinomas and human breast, colon and ovarian
cancers, as well as normal tissue counterparts (NFs). We observed
consistent upregulation of DKK3 mRNA and protein levels in
CAFs compared to NFs and cancer cells (Fig. 2a, b and Supple-
mentary Figure 2a&b). Comprehensive analysis of these models
indicated that DKK3 expression was stronger in FAP-positive
CAFs (Supplementary Figure 2b-d) but not necessarily associated
with DKK3 secretion (Fig. 2b). Noteworthy, the DKK gene DKK2
also showed a signiﬁcant enrichment in the cancerous stroma of
some tumour types (Supplementary Figure 1a). However, DKK2
expression was not restricted to CAFs in murine or human
tumours (Fig. 1g and Supplementary Figure 1d&e), nor upregu-
lated in murine or human CAFs when compared to NFs (Fig. 2a,
b and Supplementary Figure 2b). In addition, no association
between DKK2 expression and poor outcome was observed in
ER-negative BC, colon and ovarian cancer patients (Fig. 1i). For
these reasons, we decided to focus on studying the role of DKK3
in CAFs.
To investigate the mechanism leading to DKK3 upregulation in
CAFs, we ﬁrst analysed the ChEA Transcription Factor Binding
Site dataset in the Enrich database14,15. This informed of 58
transcription factors that potentially bind the DKK3 promoter
(Fig. 2c). Of these, HSF1 was the only factor to positively
modulate DKK3 expression in perturbation assays16. This was
further conﬁrmed in two independent datasets involving Hsf1
deletion in ﬁbroblasts6,17 (Supplementary Figure 2e). HSF1 is a
transcription factor that can be activated by stresses such as
oxidative stress, nutrient-deprivation and protein misfolding18,
which are commonly found in the tumour microenvironment.
HSF1 has been associated to aggressive CAF behaviours by its
ability to drive a transcriptional programme that supports the
malignant potential of cancer in a non-cell-autonomous way6.
Silencing Hsf1 expression reduced Dkk3 mRNA and protein
expression in CAFs (Fig. 2f, g). Furthermore, HSF1 activity
strongly correlated with DKK3 gene expression in the stromal
compartment of human tumours (Fig. 2h). Next, we performed
chromatin immunoprecipitation using anti-HSF1 antibodies and
extracts from murine NF and CAFs. Fig. 2i shows that Hsf1 was
signiﬁcantly more associated with the bona ﬁde HSF1 target gene
Rilpl in CAFs. Further, Hsf1 interacted with promoter and
enhancer regions of the Dkk3 locus, and this association was
signiﬁcantly increased in CAFs.
DKK3 modulates pro-tumorigenic functions in CAFs. To
investigate the functional relevance of DKK3 we silenced Dkk3
expression in murine CAF1 with 2 independent RNAi (Fig. 3a).
Knocking-down Dkk3 did not affect the expression of genes
associated to CAF phenotypes (Fig. 3b). However, the ability of
CAFs to contract collagen gels, a measure of their matrix remo-
delling capacity, was dependent on Dkk3 expression (Fig. 3c).
Decreased gel contraction in Dkk3-siRNA CAFs was associated
with thinner collagen ﬁbres (Fig. 3d) and a signiﬁcant decrease in
matrix stiffness (Fig. 3e). Similar ﬁndings were obtained in CAF5
(Supplementary Figure 3a), a CAF line that did not secrete Dkk3
(Fig. 2b). For long-term functional analyses, we generated Dkk3
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knockout CAFs (CAF-KO) and CAF-KO re-expressing Dkk3
(CAF-KO-REC)(Supplementary Figure 3b and Fig. 3f). Validat-
ing our previous results, Dkk3-null CAFs presented signiﬁcantly
less ECM remodelling activity (Supplementary Figure 3c, d). In
three-dimensional (3D) co-culture models19 (Fig. 3g), CAFs
promoted cancer cell invasion and growth of murine MMTV-
PyMT TS1 cancer cells, and this ability was dependent on Dkk3
expression (Fig. 3h, i). These results were further validated using
alternative approaches (i.e. matrigel on top) (Supplementary
Figure 3e&f) and in human patient-derived CAFs from breast,
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colorectal and ovarian cancers (Supplementary Figure 4). Con-
versely, forcing DKK3 expression in NFs (Supplementary Fig-
ure 5a) signiﬁcantly increased their abilities to remodel collagen
matrices and promote TS1 invasion (Supplementary Fig-
ure 5b&c). In CAFs, HSF1 promotes tumour growth by inducing
the production of secreted factors such as TGFβ and SDF16.
Using recombinant DKK3 and CAF-derived conditioned media
from WT, KO and KO-REC CAFs we observed that secreted
DKK3 had no effect on cancer cell proliferation and motility
(Supplementary Figure 5d). Validating these results, we observed
no signiﬁcant differences in cancer cell proliferation or motility
between cells treated with conditioned media from CAF1
(detectable secreted DKK3, as per Fig. 2b) or CAF5 (no detectable
secreted DKK3), or in the presence of a blocking antibody against
DKK3 (Supplementary Figure 5e). In addition, secreted DKK3
was not able to recover the functional defects associated to loss of
DKK3 in CAFs (Supplementary Figure 5f). Thus, DKK3 is a novel
HSF1 target gene that regulates ECM remodelling and associated
cancer cell growth and invasion; unlike other HSF1 target genes
such as TGFβ or SDF1, DKK3 does not have any apparent
secreted function.
DKK3 is required for the tumour-promoting activities of CAFs
in vivo. In vivo (Fig. 4a), we observed that tumours arising from
cancer cells co-injected with KO-CAFs grew signiﬁcantly more
slowly than those of mice co-injected with WT-CAFs or KO-
REC-CAFs, leading to increased survival (Fig. 4b, c). Conversely,
ectopic expression of DKK3 in NF signiﬁcantly increased their
ability to promote tumour growth in vivo (Supplementary Fig-
ure 5g). Histological analysis revealed that TS1+WT-CAF or
TS1+KO-REC-CAF tumours shared a poorly differentiated
morphology and invasive phenotypes typical of high-grade
tumours, with loss of basal lamina (i.e. laminin staining),
despite having similar number of αSMA-positive CAFs (Fig. 5d).
In contrast, TS1+KO-CAFs tumours had a more differentiated
architecture where cancer cell acini where surrounded by
laminin-rich areas. Fibronectin and Masson’s trichrome staining
revealed increased ECM deposition at the tumour border in TS1
+WT-CAF and TS1+ KO-REC-CAF tumours, suggesting a
higher reactive stroma. Second-harmonic generation (SHG)
imaging conﬁrmed these ﬁndings as TS1+WT-CAFs tumours
presented a higher content of collagen ﬁbres than TS1+ KO-CAF
tumours (Fig. 5f). These ECM characteristics have been linked
with aggressive CAF phenotypes as they promote cancer cell
motility and local invasion20,21. In agreement, we observed areas
at the tumour border where cancer cells were invading in TS1+
WT-CAFs tumours (Fig. 5f, asterisk). Using intravital imaging we
conﬁrmed this as co-injection of TS1 cells and WT-CAFs pro-
duced tumours where both cancer cells and CAFs were highly
motile (Supplementary Movie 1; Fig. 5g, h). In contrast, motility
in tumours with KO-CAFs was severely impaired (Supplementary
Movie 2; Fig. 5h).
DKK3 in CAFs potentiates Wnt/β-catenin and YAP/TAZ sig-
nalling. To understand the molecular mechanism whereby DKK3
exerts its functions and how HSF1 connects to other signalling
pathways, we performed global transcriptomic proﬁling of mur-
ine CAFs after Dkk3 silencing. Gene set enrichment analysis22
revealed a signiﬁcant decrease in the expression of genes asso-
ciated with Wnt/β-catenin and YAP/TAZ activities (Fig. 5a,
Supplementary Figure 6a and Supplementary Table 1). β-catenin
and YAP/TAZ are transcriptional regulators with paramount
roles in development and cancer23,24. In CAFs, YAP establishes a
transcriptional programme that enhances matrix remodelling and
invasion of neighbouring cancer cells7. β-catenin plays a pivotal
role in ﬁbrotic disorders25, but its relevance in modulating CAF
functions is still not well understood. Dkk3 knock-down
decreased levels of non-phosphorylated (active) β-catenin and
TAZ levels (Fig. 5b), reduced nuclear YAP/TAZ localisation
(Fig. 5c) and inhibited β-catenin and YAP/TAZ transcriptional
activity (Fig. 5d). These ﬁndings were conﬁrmed using Dkk3
knockout/recovery system (Supplementary Figure 6b&c) and
patient-derived CAFs (Supplementary Figure 6d-f). Conversely,
ectopic expression of DKK3 in human NFs increased non-
phosphorylated (active) β-catenin and YAP/TAZ levels (Supple-
mentary Figure 6g). Furthermore, we observed reduced β-catenin
and YAP staining in DKK3-null CAFs in vivo (Fig. 5e, f), and
DKK3 expression signiﬁcantly correlated with YAP/TAZ and β-
catenin signatures in human cancer stroma (Fig. 5g). We con-
ﬁrmed that β-catenin and YAP/TAZ were activated in murine
and human CAFs (Fig. 5h and Supplementary Figure 7a&b), and
in the stroma of breast, colorectal and ovarian cancers (Supple-
mentary Figure 7c).
DKK3 regulates CAF functions via YAP/TAZ. Using our bat-
tery of functional assays we tested whether DKK3 was regulating
CAF functions via YAP/TAZ and/or β-catenin. Contrary to YAP/
TAZ silencing, knocking-down β-catenin (Fig. 6a) had no effect
in the ability of CAFs to contract collagen-rich matrices (Fig. 6b),
or promote cancer cell invasion and growth in 3D (Fig. 6c, d).
Loss of YAP/TAZ function in CAFs leads to MLC2 and Src
Fig. 1 DKK3 is upregulated in the stroma of breast, colon and ovarian cancers. a Tukey boxplots showing z-score values of DKK3 mRNA expression in
normal and cancerous stroma from breast, colorectal and ovarian cancers (Breast: normal, n= 6; cancer, n= 53. Colon: normal, n= 4; cancer, n= 13.
Ovary: normal, n= 8; cancer, n= 31). b Representative images of DKK3 staining in breast, colorectal and ovarian cancers and normal tissues. Scale bar,
100 µm. c Tukey boxplots showing quantiﬁcation of DKK3 staining (Histoscore) in breast, colorectal and ovarian cancers and normal tissue counterparts
(Breast: normal/adjacent, n= 9; cancer, n= 109. Colon: normal/adjacent, n= 14; cancer, n= 107. Ovary: normal/adjacent, n= 8; cancer, n= 138). d Tukey
boxplots showing DKK3 Histoscore in non-invasive breast cancers (Stage 1&2), invasive breast-cancers (Stage 3&4) and normal tissue counterparts. Left
graph shows all cancers irrespective of their subtype (normal, n= 9; Stage 1&2, n= 74; Stage 3&4, n= 74). Middle graph shows ER-negative breast
cancers (normal, n= 9; Stage 1&2, n= 40; Stage 3&4, n= 40). Right graphs shows ER-positive breast cancers (normal, n= 9; Stage 1&2, n= 21; Stage
3&4, n= 21). e Disease-free survival of breast cancer patients stratiﬁed on stromal DKK3 gene expression (GSE9014, ER-negative patients). f Images show
DKK3 (green), vimentin (VIM; red) and DAPI (blue) staining of two representative human breast cancer tissues. Scale bar, 50 µm. g Tukey boxplot shows
Dkk3 mRNA expression levels (relative to Gapdh) in Cancer cells (Epcam+), immune cells (Cd45+), endothelial cells (Cd31+) and ﬁbroblasts (Pdgfra+)
from MMTV-PyMT tumorus (n= 4). h Graphs show correlations between the expression of DKK3 and ACTA2, FAP and COL1A2 in normal and cancerous
stroma from mammary gland (GSE9014), colorectal (GSE35602) and ovarian (GSE40595) human tissues. Pearson correlation coefﬁcient (r) is shown.
Each dot represents z-score values from individual patients. i Kaplan–Meier curves of recurrence-free survival, disease-speciﬁc survival and progression-
free survival of ER-negative breast cancer, colorectal cancer and ovarian cancer patients, respectively, based on DKK3 and DKK2 gene expression. Where
indicated, individual p values are shown; alternatively the following symbols were used to describe statistical signiﬁcance: *P < 0.05; **P < 0.01; ***P <
0.001; #P < 0.0001; n.s., non-signiﬁcant
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inactivation and reduced actomyosin contractility, which affects
the ability of CAFs to remodel the ECM7. Dkk3 knockdown was
associated with reduced phospho-MLC2 and phospho-Src levels
(Supplementary Figure 7d). β-catenin siRNA treatment did not
affect MLC2 or Src activation (Fig. 6a), suggesting that DKK3
loss-of-function is primarily associated to its effect on YAP/TAZ
activity. Conﬁrming this, expression of a constitutively active
mutant of YAP in Dkk3-null CAFs was able to recover their gel
remodelling and cancer cell growth promoting abilities (Fig. 6e,
f). Both DKK3 and YAP gain-of-function phenotypes were
associated with reactivation of actomyosin contractility and Src
(Fig. 6g). Overall, these data supported a model where HSF1 in
CAFs leads to DKK3 upregulation, which in turn potentiates
YAP/TAZ activity leading to increased ECM remodelling and
promotion of cancer cell growth and invasion (Fig. 6h). In
agreement, we observed that silencing Hsf1 in CAFs led to β-
catenin and YAP/TAZ inactivation (Fig. 6i and Supplementary
Figure 7e) and was associated with a reduction in the matrix
remodelling activity of CAFs (Fig. 6j). However, these defects
were prevented by constitutive expression of DKK3 or YAPS5A.
DKK3 potentiates canonical Wnt signalling in CAFs. We next
investigated the molecular mechanism whereby DKK3 modulates
YAP/TAZ. We observed that the expression levels of key reg-
ulators of YAP/TAZ function, MST1/2 and LATS kinases26, was
marginally affected in one of the Dkk3-null clones (i.e. KO.9)
when compared to wild-type and KO-REC CAFs (Supplementary
Figure 8a). However, analysis of YAP S127 phosphorylation, the
main maker of Hippo activity over YAP26–28, showed no differ-
ences after DKK3 modulation. This suggested that DKK3 might
be acting independently of Hippo signalling. To conﬁrm this, we
silenced LATS1&2 expression in wild type and KO.9 CAFs and
assessed CAF functions (Supplementary Figure 8b). Silencing
LATS1&2 increased the abilities of CAFs to remodel gels and
promote cancer cell growth (Supplementary Figure 8c, d), in line
with their negative role in YAP function. However, the presence
or absence of DKK3 did not signiﬁcantly alter the effect of
inhibiting Hippo signalling in CAF activities or YAP/TAZ levels,
excluding a role for Hippo kinases in YAP/TAZ activation
through DKK3.
Recent studies have shown that, similar to β-catenin, YAP/TAZ
stability and function are positively modulated in response to
canonical Wnt signalling29,30. Thus, association of LRP5/6 co-
receptors with Axin1 in response to Wnt stimulation displaces β-
catenin and YAP/TAZ from the destruction complex. In the
absence of LRP5/6 signal, Axin1 targets β-catenin and YAP/TAZ
b
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for degradation. Gene expression analyses indicated that
modulating DKK3 expression levels did not alter the expression
of Wnt signalling regulators (Supplementary Figure 8e). How-
ever, our previous data suggested that DKK3 depletion/ectopic
expression was affecting β-catenin and YAP/TAZ protein
expression (Supplementary Figures 6b&g and Supplementary
Figure 8a). To conﬁrm whether DKK3 was affecting the activity
of the destruction complex, we performed cycloheximide-chase
assays. Fig. 7a shows that the protein stability of β-catenin and
YAP/TAZ was severely affected in the absence of DKK3. Further
analyses revealed that LRP6 levels at the cell surface were
diminished when Dkk3 was knocked-out (Fig. 7b), suggesting that
DKK3 was affecting YAP/TAZ activity and CAF functions at the
level of LRP5/6. In agreement, targeting Lrp5/6 expression in
WT-CAFs (Supplementary Figure 8f), attenuated β-catenin and
YAP activation (Fig. 7c and Supplementary Figure 8f) and
diminished their tumour-promoting activities (Fig. 7d, e). Yet,
silencing Lrp5/6 expression in Dkk3-null CAFs had no functional
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consequences. Inhibiting canonical Wnt signalling with
XAV93931 yielded similar results (Supplementary Figure 7g&h),
suggesting that this was a canonical Wnt-related function. To
further conﬁrm this, we investigated the role of DKK3 in CAFs
after Wnt ligand stimulation. We observed that stimulation of
wild type and Dkk3-null CAFs with canonical Wnt ligand Wnt3a
induced a signiﬁcant increase in their basal (i.e. low serum) gel
remodelling activities, whereas non-canonical Wnt5a stimulation
had no effect (Fig. 7f). Even though DKK3 was not absolutely
required for CAFs to respond to Wnt3a, the gel remodelling
activities of CAFs after Wnt3a stimulation were signiﬁcantly
reduced in the absence of DKK3. Importantly, these effects were
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concomitant with β-catenin and YAP activation (Fig. 7g, h),
indicating that DKK3 promotes YAP/TAZ signalling by poten-
tiating Wnt signalling in CAFs.
DKK3 disable the negative Wnt regulator Kremen1&2 in
CAFs. DKK proteins have been shown to inhibit Wnt signalling
by triggering LRP5/6 internalisation through formation of a
ternary complex with Kremen1/2 receptors9,10. This is in striking
contrast with our observations on the role of DKK3 in CAFs, and
underline the functional differences of DKK proteins reported in
other systems32–34. DKK3 is an unusual member of the family as
it does not interact with LRP5/6 but still can interact with
Kremen9,10,35. Using HEK293T cells, it has been proposed that
DKK3-Kremen interaction negatively affects surface expression of
Kremen, which may favour canonical Wnt signalling by still
unclear mechanisms35. We ﬁrst conﬁrmed that Kremen1 but not
LRP6 immunoprecipitated with DKK3 in CAFs (Fig. 8a). In
addition, DKK3-Kremen1 co-localised to internal structures;
however, after DKK3 silencing Kremen1 localised to the cell
periphery (Fig. 8b), in an opposite pattern to LRP6 localisation
(Fig. 8c). Interestingly, DKK3 expression was inversely associated
to changes in Kremen1&2 protein expression (Fig. 8d). mRNA
levels of Kremen1/2 were not altered after Dkk3 silencing (Sup-
plementary Figure 8e), suggesting a post-translational regulation.
Cycloheximide-chase assays conﬁrmed that Kremen1 was less
stable in WT-CAFs than in Dkk3-null CAFs whereas
LRP6 stability was increased (Fig. 8e). Our data suggested that
disabling Kremen activity may restore LRP6 functions in the
absence of DKK3 expression. In agreement, silencing Kremen
receptors in Dkk3-null CAFs (Fig. 8f) increased their abilities to
remodel gels (Fig. 8g) and promoted cancer cell growth and
invasion (Fig. 8h, i). These changes were associated with con-
comitant re-localisation of LRP6 to the cell surface (Fig. 8j) and
reactivation of YAP/TAZ and β-catenin signalling (Fig. 8f, k).
Conversely, knocking-down Kremen1&2 in DKK3-expressing
CAFs had no functional consequences (Supplementary Figure 8i).
Overall, our mechanistic analyses support a model whereby
DKK3 stabilises the cell-surface levels of LRP6 by uncoupling
LRP6 from the Kremen-mediated internalisation machinery. In
turn, DKK3-mediated LRP6 regulation leads to activation of β-
catenin and YAP/TAZ, with the latter being the main mediator of
DKK3 functions (Fig. 9).
Discussion
Secreted DKK proteins are emerging as unpredicted
tumour-promoting factors due to their immune-suppressive
activities32,34,36. Here, we demonstrate that the family member
DKK3 can also promote aggressive behaviours in CAFs in a cell
autonomous manner. DKK3 reduces YAP/TAZ degradation by
potentiating Wnt signalling, thus acting in parallel to YAP/TAZ
regulation via mechanotransduction7,37. DKK3 also activates β-
catenin in CAFs and we document that cancer stroma and CAFs
present increased β-catenin activity. However, inhibition of β-
catenin by RNAi did not affect CAF-mediated ECM remodelling,
cancer cell growth and invasion. Further studies are required to
determine if β-catenin modulates other pro-tumorigenic func-
tions in CAFs such as potentiating the tumour initiating capacity
of cancer cells or immune suppression12. The role of DKK3 as a
positive regulator of canonical Wnt is in contrast to the well
documented role of other DKK family members. Here, we pro-
vide mechanistic insights into these differences. Contrary to what
has been shown for DKK1 and DKK2, we show that DKK3 does
not bind LRP6 co-receptor in CAFs, and therefore cannot fulﬁl
the bona ﬁde antagonist role of DKK proteins in canonical Wnt
signalling. By contrast, we demonstrate that DKK3 perturbs the
negative regulator Kremen and enhances Wnt signalling via
LRP6.
Whilst several CAF effectors have been identiﬁed, an unan-
swered question is how the coordination of different signalling
pathways involved in their control is established. Our results
suggest that HSF1-dependent DKK3 upregulation could be a
response of stromal ﬁbroblasts to stresses found in the tumour
microenvironment. In turn, DKK3 expression promotes ﬁbro-
blast activation as it sustains crucial activating pathways. Thus,
DKK3 expression potentiates canonical Wnt signalling, leading to
reduced YAP/TAZ degradation. This leads to YAP/TAZ activa-
tion, ECM stiffening and the generation of aggressive tumour
microenvironments. We propose that this may be a mechanism
for tumour-promoting CAFs to be selected as tumour progresses
and a plausible mechanism explaining its signiﬁcant enrichment
in cancer stroma. Further work is still required to understand the
processes modulating HSF1 activity in CAFs, and whether the
axis HSF1-DKK3-YAP is also relevant in other systems.
To conclude, we identify a key role of DKK3 in tumour stroma.
It is required for many of the pro-tumorigenic functions of CAFs,
including matrix stiffening and cancer cell growth and invasion.
High levels of DKK3 in the stroma are sustained by HSF1,
potentiate Wnt signalling and reduce YAP/TAZ degradation.
Thus, DKK3 acts as a crucial integrator of key molecular players
modulating the emergence of tumour-promoting phenotypes in
CAFs.
Methods
Mouse strains. Transgenic FVB/n mice expressing the Polyoma Middle T antigen
oncogene under the Mouse Mammary Tumour Virus promoter (MMTV-PyMT)38
Fig. 4 DKK3 promotes the pro-tumorigenic behaviour of CAFs in vivo. a Cartoon describing the experimental set-up used to assess the tumour-promoting
potential of CAFs in vivo by subcutaneous co-injection of TS1 murine cancer cells and indicated CAFs. b Graph showing the volumes of tumours in
syngeneic mice (FVB/n) at the indicated days post-injection. Lines represent mean ± SEM (n= 7 or more individual tumours). c Survival curves for
tumours as described in (b), representing the percentage of animals alive at the indicated time point after injection. Individual p values are shown.
d Representative images showing Masson’s trichrome, ﬁbronectin (FN), laminin and αSMA staining of indicated tumours at day 14 post-injection. Scale
bars, 100 µm. e Charts show quantiﬁcation of positive areas relative to total areas for stainings in (d). Bars indicate mean ± SEM (n= 4 individual tumours
except for WT-CAF tumours that n= 5). f Representative images of intravital imaging of tumours generated by co-injection of TS1 cancer cells (red) with
CAF-WT or CAF-KO.9 CAFs (green) in CD-1 nude mice at day 20. Collagen ﬁbres (blue) were imaged by SHG. Asterisk indicates areas of cancer cell
invasion at the tumour border. Scale bars, 100 µm. Tukey boxplot shows collagen content as calculated by SHG intensity, n= 24 or more ﬁelds of view at
the tumour border from 3 independent tumours. g Representative time-lapse images from intravital imaging of TS1 (red) and CAF-WT (green) tumours in
CD-1 nude mice. Collagen ﬁbres (blue) were imaged by SHG. Zoom-up areas with cancer cell movement associated to a CAF (Area 1, asterisk), cancer cell
movement towards a CAF-enriched area (Area 1, arrow) and CAF movement (Area 2, hashtag) are also shown. Scale bar, 50 µm. h Graph showing analysis
of cancer cell and CAF movement by intravital imaging. Bars indicate average number of moving cells per ﬁeld of view ± SEM (CAF-WT, n= 23 ﬁelds of
view from 3 independent tumours; CAF-KO, n= 14 ﬁelds of view from 2 independent tumours). For all graphs, *P < 0.05; **P < 0.01; ***P < 0.001; #P <
0.0001; n.s., non-signiﬁcant
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Fig. 5 DKK3 potentiates β-catenin and YAP/TAZ signalling in CAFs. a Graph showing GSEA of murine CAF1 after transfection with control siRNA (CAF-
siCtr) vs CAF1 after transfection with DKK3 siRNAs (si#2 and si#3). The graph indicates the Normalised Enrichment Score (NES) and False Discovery Rate
(FDR) q-value (-log2) for each gene set. In green, top differential gene-sets, including β-catenin and YAP/TAZ. b Western blot showing DKK3, non-
phospho (active) β-catenin (Ser33/37/Thr41), β-catenin, TAZ,YAP and Gapdh levels in CAF1 after transfection with control (siCtr) and two independent
DKK3 siRNA. c Images show YAP (left panels) or TAZ (right panels) localisation (green) and DAPI staining (red) in CAF1 after transfection with control
(siCtr) and two independent DKK3 siRNA. Scale bars, 20 µm. d Tukey boxplots show luciferase activity (Fireﬂy/Renilla) indicative of β-catenin activation
(TOPFlash reporter) or YAP/TAZ activation (4xGTIIC-lux reporter) in CAF1 after transfection with control (siCtr) or DKK3 (si#2&3) siRNAs; n= 9 for β-
catenin, n= 17 for YAP/TAZ. e Left panels show total β-catenin (green), S100A4 (CAF marker, red) and DAPI (blue) staining of TS1 tumours admixed with
WT or KO.9-CAFs. Right panels show processed images showing β-catenin staining in CAF-positive areas. Scale bar, 100 µm. Chart shows mean β-catenin
intensity in CAFs. Bars represent mean ± SEM (n= 4 ﬁelds of view). f Left panels show total YAP (green), S100A4 (CAF marker, red) and DAPI (blue)
staining of TS1 tumours admixed with WT or KO.9-CAFs. Right panels show processed images showing YAP staining in CAFs. Scale bar, 100 µm. Chart
shows mean YAP intensity in CAFs. Bars represent mean ± SEM (n= 19 or more ﬁelds of view). g Graphs show correlations between DKK3 gene
expression and the expression of CAF-speciﬁc YAP/TAZ and β-catenin signatures (z-score normalised) in normal and cancerous stroma from mammary
gland, colorectal and ovarian human tissues. Pearson correlation coefﬁcient (r) and p values are shown. h Representative Western blot showing non-
phospho (active) β-catenin (Ser33/37/Thr41), β-catenin, TAZ, phospho-S127-YAP, YAP and tubulin in murine NF1, N4, CAF1 and CAF5. For all graphs,
*P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.0001; n.s., non-signiﬁcant
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were used for tumour cell isolation and FACS analysis. Wild-type FVB/n and CD-1
Nude mice (Charles River) were used as recipients for tumours. All animals were
kept in accordance with UK regulations under project license PPL80/2368.
Cell lines. Established murine ﬁbroblasts from FVB/n normal mammary glands
(NFs) and MMTV-PyMT mammary carcinoma (CAFs) have been previously
described7,39. Human ﬁbroblasts from normal mammary glands and breast car-
cinomas were provided by Julia Tchou (University of Pennsilvania, USA)40 and
Clare Isacke (Institute of Cancer Research, UK). Human ﬁbroblasts from rectal
carcinomas (RC11), colon carcinomas (CAF25) and adjacent normal tissue (NAD-
D) were provided by Danijela Vignjevic (Institute Curie, France). Human ﬁbro-
blasts from ovarian carcinoma (EOC.TIL.04) were provided by Marco Donia
(University of Copenhagen, Denmark). Human CAFs from cervical (Cer-CAF)
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(pMLC2) and Tubulin in CAF1 following transfection with control (siCtr), β-catenin (siβcat; smart-pool) or YAP/TAZ (siY/T; smart-pool) siRNAs. b Tukey
boxplot shows gel contraction of CAF1 transfected as in (a); n= 8 gels except for siY/T that n= 6. c Tukey boxplot shows invasion index (3D invasion)
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d Representative images of end-point TS1 (red) MOT co-culture with CAF1 transfected as in (a). Scale bar, 100 µm. Graph shows the area of colonies. Bars
represent mean ± SEM (n= 570 or more colonies from at least 3 independent experiments). e Tukey boxplot shows gel contraction index of CAF-WT or
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control (siCtr) or Hsf1 (smart-pool) siRNAs. Bars represent mean ± SEM (n= 3 or more). A dashed red line indicates the average contraction by KO.9
CAFs. For all graphs, *P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.0001; n.s., non-signiﬁcant
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Fig. 7 DKK3 potentiates canonical Wnt signalling and affects YAP/β-catenin degradation. a Western blots show β-catenin, TAZ, YAP and tubulin
expression in murine WT and KO.9 CAFs after treatment with 100 μg mL−1 cycloheximide (CHX) for the indicated times (in min). Graph represents
quantiﬁcation of the indicated blots (normalised to tubulin) at 180min relative to the amount at 0min. b Low and high magniﬁcation images of LRP6
(green), F-actin (red) and DAPI (blue) staining of murine WT, KO.9 and KO.9-REC CAFs in 1% FBS. Scale bars, 15 μm. c Images show YAP (green) and
DAPI (red) staining of CAF1 after transfection with control (siCtr) and LRP5&6 siRNA (smart-pool). Bar, 50 µm. Graph shows quantiﬁcation of nuclear
relative to cytosolic ﬂuorescent intensity (log10 ratios) of YAP. Lines represent mean ± SEM. d Graph shows gel contraction index of murine WT and KO.9
CAFs after transfection with control (siCtr) or Lrp&6 (siLrp5/6) siRNAs. Bars represent mean ± SEM (n= 3 or more). e Graph shows the area of colonies
formed by TS1 MOT co-culture with WT and KO.9 CAFs after transfection with control (siCtr) or Lrp5&6 (siLrp5/6) siRNAs. Bars represent mean ± SEM
(n= 584 or more colonies from at least 3 independent experiments). f Graph shows gel contraction of WT and KO CAFs cultured in 5% FBS and
stimulated with vehicle or 200 ngmL−1 of Wnt3a or Wnt5a. Bars represent mean ± SEM (n= 3). KO data are merged results of KO.2, KO.7 and KO.9 on
triplicate (n= 9). g Western blot showing levels of non-phospho (active) β-catenin (Ser33/37/Thr41), β-catenin, YAP, TAZ and Gapdh in WT and KO.9
CAFs after stimulation with vehicle (−) or 200 ngmL−1 of Wnt3a for 3 h. Graph represents quantiﬁcation of blots indicating the fold levels normalised to
Gapdh. h Images show YAP (green) and DAPI (red) staining of murine WT and KO.9 CAFs after 16 h starvation followed by stimulation with vehicle
(Starvation) or 200 ngmL−1 of Wnt3a for 3 h. Bar, 50 µm. Graph shows quantiﬁcation of nuclear relative to cytosolic ﬂuorescent intensity (log10 ratios) of
YAP. Lines represent mean ± SEM. Individual p values for different comparisons are shown. For all graphs, *P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.0001;
n.s., non-signiﬁcant
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(blue) staining of human BC-CAF TB165 after transfection with control (siCtr) and DKK3 siRNA (smart-pool). Scale bars, 15 µm. c Images show LRP6
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Kremen2, DKK3 and Gapdh expression in WT and KO.9 CAFs. e Western blots show LRP6, Kremen1 and tubulin expression in indicated CAFs after
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YAP. Lines represent mean ± SEM. For all graphs, *P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.0001; n.s., non-signiﬁcant
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squamous cell carcinoma have been previously described7. Human primary
ﬁbroblasts were expanded and immortalised using hTERT virus (pCSII vector
backbone) followed by selection with hygromycin. All resulting ﬁbroblast popu-
lations were assessed for ﬁbroblast and CAF marker expression and thoroughly
characterised7. All ﬁbroblasts were cultured in DMEM (Sigma), GlutaMax (Gibco),
10% FBS, 1% insulin-selenium-transferrin (ITS, Gibco). MMTV-PyMT TS1
murine breast cancer cells were used in most assays and to generate tumours in
syngeneic FVB/n mice. Human breast cancer cell line BT20 was cultured in MEM
plus GlutaMAX and 10% FBS. Colon cancer cell line HCT116 was grown in
McCoy 5 A (with 1% GlutaMAX and 10% FCS). Ovarian cancer cell line SKOV3
was grown in RPMI with 1% GlutaMAX, 10% FBS and 1% Pyruvate. All cell lines
were grown in a standard humidiﬁed 5% CO2 incubator at 37 °C and tested
negative for mycoplasma infection with MycoAlertTM (Lonza). CAFs and cancer
cell lines were ﬂuorescently labelled using the following lentiviral vectors, as
indicated: EGFP-CAAX pCSII-IRES2-hygro, ECFP-CAAX pCSII-IRES2-hygro,
ORANGE-CAAX PCSII-IRES2-hygro, mCherry-CAAX pCSII-IRES2-hygro and
pCSII-IRES2-blasti-eGFP.
cDNA, RNAi and reagents. DKK3 (a kind gift by Peter Berger, University of
Innsbruck) was ectopically expressed in CAF/NFs lines using a pLENTI6 lentiviral
vector system. shRNAs targeting human DKK3 were cloned into the lentiviral
vector pLKO.1-TRC-cloning vector (Addgene, Plasmid #10878) at AgeI/EcoRI
restriction sites according to the online Addgene protocol (www.addgene.org/tools/
protocols/plko). shRNA sequences were obtained from the GPP Web Portal (Broad
Institute, http://portals.broadinstitute.org/gpp/public/). A list of the respective
shRNA sequences can be found in Supplementary Table 3. siRNAs were purchased
from Dharmacon and are listed in the Supplementary Table 4. For in vitro treat-
ments the following growth factors and drugs were used: recombinant human
DKK3 (R&D, 1118-DK-050), XAV939 (Sigma, X3004), Cycloheximide (Sigma,
C7698), Wnt3a (R&D, 5036-WN-010) and Wnt5a (R&D, 645-WN-010). Lentiviral
plasmid for expression of mutant YAP was 5SA-YAP1-YFP vector (kind gift of Eric
Sahai, Crick Institute).
Generation of CRISPR knockout cell lines. The CRISPR plasmid U6-gRNA/
CMV-Cas9-GFP containing a guide RNA targeting mouse DKK3 was purchased
from Sigma (MM0000346166). CAF1 cells (CAF-WT) were transfected with the
plasmid using Lipofectamine (Life Technologies) following manufacturer’s
instructions and GFP positive cells were single sorted into 96 well plates after 24 h.
GFP-negative clones were also sorted as controls (e.g. WT.9). Individual cell clones
were expanded and the DKK3 locus targeted by CRISPR was sequenced for
knockout validation. In addition, loss of DKK3 protein expression was also con-
ﬁrmed by immunoblotting to generate DKK3-null CAFs (CAF-KO). DKK3-null
clones were infected with DKK3-expressing lentivirus to generate KO-CAFs re-
expressing DKK3 (CAF-KO-REC).
Conditioned media. CAF-derived conditioned media was generated by culturing a
conﬂuent monolayer of cells in DMEM 2.5% or 5% FBS for 48 h. Media was then
recovered and ﬁltered through a 0.22 μm ﬁlter and used as indicated. For detection
of DKK3 in the conditioned media, 50 μL of StrataClean resin (Agilent Technol-
ogies UK Ltd, 400714) were added to 1 mL of media. Each sample was vortexed for
1 min, left at RT for 1 min and spun 15,000× g for 5 min at 4 °C. The supernatant
was then removed and the beads were prepared in protein sample buffer to be
resolved in SDS-PAGE.
Transfections. Fibroblasts were seeded at 60% conﬂuency and transfected using
DharmaFECT 1 (Dharmacon) for siRNA (100 nM ﬁnal concentration), and
Lipofectamine (Life Technologies) for plasmids following manufacturer’s instruc-
tions. Cell lines stably expressing cDNA (DKK3 or GFP/CFP/mCherry) or shRNAs
were generated by lentiviral infection followed by puromycin selection for 2 weeks
(2 μg mL−1). Alternatively, ﬂuorescent-labelled cells were sorted by FACS.
ECM-remodelling assay. To assess force-mediated matrix remodelling, 7.5 × 104
murine ﬁbroblasts or 3–5 × 104 human ﬁbroblasts were embedded in 120 µL of a
mixture of collagen I (BD Biosciences) and ECM gel mixture (Sigma) yielding a
ﬁnal collagen concentration of ~4.6 mgmL−1 and a ﬁnal ECM gel mix con-
centration of ~2.2 mgmL−1 (Collagen-rich matrix hereafter). Once the gel was set,
cells were maintained in ﬁbroblasts medium. Gel contraction was monitored daily
by scanning the plates. Unless stated otherwise, the gel contraction value refers to
the contraction observed after 2 days. To obtain the gel contraction value, the
relative diameter of the well and the gel were measured using ImageJ software, and
the percentage of contraction was calculated using the formula 100 × (well area−
gel area) / well area. When indicated, gels were ﬁxed in 4% paraformaldehyde
(PFA) for 16 h and processed for immunoﬂuorescence. Backscattered light
(reﬂectance) was collected to image the matrix surrounding cells. Alternatively,
collagen second-harmonic generation (SHG) signal was acquired by exciting with
an 880 nm pulsed Ti–Sapphire laser and acquiring emitted light at 440 nm using a
Leica SP8 microscope.
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Fig. 9 Model depicting the proposed mechanism of DKK3-mediated regulation of YAP/TAZ and β-catenin in CAFs. On CAFs, DKK3 destabilises Wnt
negative regulator Kremen leading to increased LRP6 membrane localisation, which in turn stabilises YAP/TAZ and β-catenin levels via canonical Wnt.
Whereas β-catenin signalling is dispensable for CAFs to remodel the ECM and promote cancer cell growth and invasion, DKK3-driven YAP activation is
required to induce a tumour-promoting phenotype. Absence of DKK3 in DKK3-null CAFs and NFs is associated with decreased YAP/TAZ and β-catenin
activity. In CAFs, loss of DKK3 leads to concomitant upregulation of Kremen, LRP6 inactivation and YAP/TAZ and β-catenin destabilization. In this
scenario, depletion of Kremen1/2 is able to rescue LRP6 membrane localisation and YAP/TAZ and β-catenin activity
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3D co-culture. The 3D co-culture spheroid assay was adapted from Dolznig et al19.
In short, cancer cells were seeded in low numbers (200 cells per well TS1-mCherry,
50 cells per well HCT116-mCherry, 150 cells per well BT20-GFP and SKOV3-
orange) in ultra-low adherent cell culture plates (Corning) to form spheroids for
48 h. The spheroids were collected and mixed with 1 × 105 ﬁbroblasts. The spheroid
and ﬁbroblast suspension was centrifuged at 200× g for 4 min and the supernatant
was carefully removed. The pellet was ﬁrst re-suspended in 30 µL of medium and
then mixed with 270 µL of Collagen-rich matrix. The 300 µL gel containing the
spheroids and ﬁbroblasts was seeded in a glass-bottom 3.5 cm MatTek dish. A
nylon ﬁlter (Nylon NET ﬁlters 120 μm, Merck Millipore) with a hole of ~1 cm
diameter cut out at the centre was added to prevent excessive gel contraction. The
gel was set for 1 h in the incubator at 37 ˚C and cancer cell medium was added. The
spheroids were incubated for 5–7 days (3–5 days for studies involving siRNA-
transfected CAFs) and then ﬁxed with 4% PFA and either imaged directly or
stained additionally with DAPI and phalloidin-TRITC or phalloidin-FITC. Sam-
ples were mounted and analysed using a Leica SP8 confocal microscope. Confocal
sections were acquired for individual spheroids from bottom to top, z-stack pro-
jections were analysed using ImageJ and data analysed in GraphPad Prism. The
invasion index was calculated by measuring the total area over which cancer cells
had dispersed (including invading and non-invading cells) and the area of non-
invading cells (1 – [non-invading area/total area]). To calculate tumour growth
index, area covered by cancer cells in each spheroid was calculated.
Matrigel on Top (MOT) co-culture. 24-well MatTek glass bottom plates were
pre-coated with 100 µL of Matrigel. Next, 6 × 104 CAFs per well were seeded, unless
otherwise stated. After 1 h, ﬂuorescently labelled cancer cells (2 × 104 per well) were
seeded and allowed to adhere for 4 h. Growth medium was exchanged to DMEM
2.5% FCS and 2% Matrigel and co-cultures were allowed to grow for 48 h, or up to
120 h for the ovarian cells. Co-cultures were then ﬁxed in 4% PFA and analysed by
confocal microscopy. Images were analysed using ImageJ and data analysed in
GraphPad Prism. To calculate cancer cell growth index, area covered by cancer
cells in each ﬁeld of view was calculated.
Atomic force microscopy. To assess the elastic modulus of gels remodelled by
ﬁbroblasts, 75 × 103 ﬁbroblasts were embedded in 100 µL of Collagen-rich matrx
and seeded on ultra-low attachment 96-well plate (Costar). Once the gels were set,
they were maintained in ﬁbroblast medium. After three days, the elastic modulus of
the gels was measured as previously described7. Gels were gently lifted from their
well and ﬁxed in the centre of 50 mm glass bottom Petri dishes using cyanoacrylate
superglue. Once glued, Leibovitz L-15 medium (Invitrogen) supplemented with
10% FCS was added to the dish. AFM measurements were performed with a JPK
Nanowizard-I (JPK instruments, Berlin, Germany) interfaced to an inverted optical
microscope (IX-81, Olympus). AFM cantilevers with pyramidal tips (MLCT,
Bruker, Karlsruhe, Germany) and nominal spring constants of 0.07 Nm−1 were
modiﬁed by gluing 35-μm radius glass beads to the cantilever underside with UV
curing glue (UV curing, Loctite, UK). Cantilever spring constants were determined
prior to modiﬁcation using the thermal noise method implemented in the AFM
software (JPK SPM). Prior to any indentation tests, the sensitivity of the cantilever
was set by measuring the slope of force-distance curves acquired on glass regions of
the Petri dish. Using the optical microscope, the tip of the cantilever was aligned
over regions in the middle of the gel and, for each gel, measurements were acquired
in 30–40 locations ~100 μm apart. Force-distance curves were acquired with an
approach speed of 5 μm.s−1 until reaching the maximum set force of 3 nN. After
the experiment, the elastic moduli were extracted from the force-distance curves by
ﬁtting the contact portion of curves to a Hertz contact model. For each force-
distance curve, goodness of ﬁt was evaluated by calculating r^2 values and only ﬁts
with r^2 > 0.80 were retained for further analyses (representing on average 80% of
the acquired force-curves).
Immunoﬂuorescence. Cells were ﬁxed in 4% PFA for 1 h and permeabilised by
incubation in PBS 0.2% Triton 100 (Sigma) at RT for 20 min. For HSF1 immu-
noﬂuorescence, cells were permeabilised by incubation in PBS 0.5% NP-40 (Sigma)
at 4 °C for 20 min (twice), in PBS 0.3% Triton 100 (Sigma) at RT for 20 min and in
PBS 0.1% Triton 100 at RT for 15 min (twice). Where indicated (non-permeabi-
lised), this step was not performed. Samples were blocked for 60 min at RT in
blocking solution: 4% BSA PBS 0.05% Tween20 (Sigma). Then, cells were incu-
bated with primary antibody in blocking solution in a wet chamber overnight at
4 °C. After three washes of 15 min in PBS, secondary antibody in blocking solution
was added for 3 h. After three washes of 15 min in PBS, the samples were mounted
and analysed using a Leica SP8 confocal microscope. To quantify β-catenin acti-
vation by immunoﬂuorescence, for each ﬁeld of view we calculated the area positive
for active-β-catenin staining per cell using Volocity. These values were then nor-
malised to the mean value of CAF-WT (murine CAFs) or control siRNA-
transfected cells (human CAFs). To quantify YAP and TAZ activation by immu-
noﬂuorescence, we measured their nuclear localisation using Volocity. Brieﬂy, we
calculated for each cell the total intensity of nuclear HSF1, YAP or TAZ staining
(determined by the intensity within the region delimited by DAPI staining) and
perinuclear staining (deﬁned as a region encompassing two to seven pixels from the
nucleus border). Nuclear/cytoplasmic YAP and TAZ ratios were calculated as the
log10 of the total nuclear intensity/mean perinuclear region intensity per cell. For
the analysis of human CAFs, nuclear/cytoplasmic YAP and TAZ ratios were
normalised to the mean ratio of control siRNA-transfected cells. Antibody
description and working dilutions can be found in Supplementary Table 2.
Tissue immunohistochemistry and immunoﬂuorescence. For histological ana-
lysis, tumours were dissected into 10% neutral buffered formalin, embedded in
parafﬁn blocks and serial sections were taken. Parafﬁn-embedded tissue sections
were rehydrated before antigen retrieval using pH 6 sodium citrate buffer. After
blocking endogenous peroxidase (DAKO peroxidase block), sections were incu-
bated for 1 h at RT with primary antibodies. For DKK3 staining, four antibodies
(Abgent AP1523a, R&D AF1118, Sigma HPA011868 and Santa-Cruz H130) were
tested for speciﬁcity using western blot and cell pellets in control and DKK3-
silenced CAFs, and then optimised for TMA analysis. Both Sigma and Santa-Cruz
antibodies yielded satisfactory results. Data presented correspond to Santa-Cruz
DKK3 antibodies. Sections were incubated with secondary antibodies for 50 min at
RT, treated with 3,30-diaminobenzidine and counterstained with haematoxylin.
Images were acquired using a Digital Slide Scanner (Hamamatsu Photonics).
Images were analysed using Volocity and data analysed in GraphPad Prism. For
each staining, positive area was calculated and normalised to the total area for all
slices processed. For immunoﬂuorescence, after antigen retrieval sections were
incubated with 0.2% Triton X-100 (Sigma) 10% Goat serum (Sigma) blocking
solution for 1 h RT. Sections were incubated overnight at 4 °C with primary
antibodies diluted in PBS. After washing, the sections were incubated with
ﬂuorescent-conjugated secondary antibodies (AlexaFluor) diluted in PBS for 1 h at
RT. Confocal images were captured using a Leica SP8 microscope. Quantitative
analysis of YAP and β-catenin staining in the tumour stroma was performed using
Volocity software. Brieﬂy, ﬁbroblasts were identiﬁed using automated threshold
based on S100A4 staining. The mean intensities of YAP and β-catenin were then
measured. In addition to haematoxylin and eosin staining and Masson’s trichrome
staining, antibody description and working dilutions can be found in Supple-
mentary Table 2.
Tissue microarrays. The following tissue microarrays were purchased from US
Biomax, Inc: breast cancer (BR1504b), colon cancer (CO2083) and ovarian cancer
(OV2001a). Formalin-ﬁxed, parafﬁn-embedded (FFPE) sections were depar-
afﬁnized, blocked with 3% H2O2 and antigen retrieval was performed using a
pressure cooker with Dako citrate buffer (pH 6.0). Slides were incubated with
DKK3 antibody (DKK-3 H-130, Santa Cruz, sc-25518) for 1 h at RT. Visualisation
was achieved with 3,30-diaminobenzidine as a chromogen (Dako Envision+
System). Images were acquired using a Digital Slide Scanner (Hamamatsu Pho-
tonics). DKK3 staining was quantiﬁed using the weighted Histoscore method to
give a value of 0–30041.
Tissue digestion for cell isolation and FACS analysis. MMTV-PyMT tumours
were minced with a scalpel and digested with a mixture of DNase and Liberase
(Roche Diagnostics). On enzymatic digestion, samples were passed through a 100-
μm ﬁlter. Cells were incubated for 5 min at RT in 2 mL NH4Cl solution (0.8% in
H2O) to eliminate red blood cells. Cells were then directly used for FACS staining
and sorted with a FACSAria ﬂow cytometer (BD Biosciences). Single cell sus-
pensions of tumour cells were labelled with FITC Rat Anti-Mouse CD45 Clone 30-
F11 (BD Pharmingen™, 553079), APC Rat Anti-Mouse CD31 Clone MEC 13.3 (BD
Pharmingen™, 561814), PE/Cy7 anti-mouse CD326 (Ep-CAM) (BioLegend,
118215) and PE anti-mouse CD140a (PDGFRa) (BioLegend, 135905). For cell
sorting, four populations (CD45+ for immune cells, CD31+ for endothelial,
EPCAM+ for epithelial and PDGFRA+ for CAFs) were collected and processed for
RNA extraction and qRT-PCR.
Proliferation analysis. For proliferation analyses with conditioned media, TS1
cancer cells were seeded at 5,000 per well in a 24-well plate in duplicates and
incubated with media containing 5% FBS (vehicle) or 5% FBS plus 100 ng mL−1
recombinant DKK3 (rDKK3), or with CAF conditioned medium (5% FBS) for
72 h. Where indicated, blocking antibody for DKK3 (R&D AF1118) or isotype
control (R&D AB-108-C) were added at 1 µg mL−1. AlamarBlue® assay was used
according to manufacturer’s instructions to compare cell growth and viability.
Scratch Wound healing assay. TS1 cancer cells were cultured to a conﬂuent
monolayer in 24-well plates. A straight scratch was made on the cell layer using a
200 µL tip across the centre of the well. Cell debris was removed by washing twice
with PBS and cells were incubated with media containing 5% FBS (vehicle) or 5%
FBS plus 100 ng mL−1 recombinant DKK3 (rDKK3), or with CAF conditioned
medium (5% FBS). Where indicated, blocking antibody for DKK3 (R&D AF1118)
or isotype control (R&D AB-108-C) were added at 1 µg mL−1. Cell migration was
monitored for 40 h using live cell imaging in the IncuCyte® (Essen Bioscience) in a
standard humidiﬁed 5% CO2 incubator at 37 °C. The wounded area at start and
end of experiment was measured using ImageJ. Wound closure was calculated as
the percentage of healed area (area at t0 minus area at t40) to the starting wounded
area.
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Co-Immunoprecipitation. For Kremen1 and DKK3 co-inmunoprecipitations,
CAFs expressing empty vector of Flag-DKK3 were lysed in immunoprecipitation
lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton-X-100, 10% gly-
cerol, 2 mM EDTA, 25 mM NaF and 2mM NaH2PO4) containing protease and
phosphatase inhibitor. Lysates were pre-cleared using G-sepharose, incubated with
anti-Flag antibody (rabbit) or IgG immobilised on G-sepharose beads at 4 °C
overnight. Beads were then washed ﬁve times with lysis buffer and eluted with
20 μL of 2x SDS sample buffer.
Western blotting. Protein lysates and immunoprecipitants were processed fol-
lowing standard procedures. Enhanced-chemiluminescence signal was acquired
using an Azure Biosystems c600. Exposures within the dynamic range were
quantiﬁed by densitometry using ImageJ. Antibody description and working
dilutions can be found in Supplementary Table 2. Immunoblot images in Figures
and Supplementary Figures show molecular weight markers in kDa. Supplemen-
tary Figure 9 shows the uncropped images corresponding to the panels displayed in
the main ﬁgures.
Luciferase reporter assays. The following plasmids were used for luciferase
reporter assays: TEAD‐reporter construct (8xGTIIC-luciferase, Addgene, Plasmid
#34615), TOP‐reporter construct (M50 Super 8x TOPFlash, Addgene, Plasmid
#12456) and CMV-Renilla (pGL4.75[hRluc/CMV], Promega). CAFs were seeded
in 6-wells plates at 70% conﬂuency. Cells were transfected with 2 µg TOPFlash or
TEAD‐reporter and 100 ng of CMV-Renilla cDNA constructs using Lipofectamine
3000 according to the manufacturer’s instructions. Cells were lysed 48 h after
transfection in 100 μL of lysis buffer (Promega). Aliquots of the cell lysates were
used to read luciferase emission using Dual-Glo® Luciferase Assay System (Pro-
mega) according to the manufacturer’s instructions. Luciferase activities were
normalised to Renilla activity.
Generation of syngeneic orthotopic tumours. MMTV-PyMT TS1 murine breast
cancer cells were used to generate tumours in wild-type FVB/n. Brieﬂy, 106
TS1 cells and 3 × 106 CAF (WT, KO.9 or KO.9-REC) were suspended in 100 μL of
PBS:Matrigel (50:50) and injected subcutaneously into 6–8 week old females.
Tumour size was measured every other day using callipers. To calculate tumour
volume the formula V= (length × width2) / 2 was used. Mice were killed once
tumours reach the maximum allowed size.
Intravital imaging. The implantation of an orthotopic mammary imaging window
in CD-1 nude mice was performed as previously described42. Forty-eight hours
after surgical implantation of the imaging window, a mixture of 1 × 106 CAFs
(GFP) and 4 × 105 TS1 (CAAX-mCherry) cancer cells in a PBS:Matrigel solution
(50:50) were injected under the window. Intravital 2-photon imaging was per-
formed at speciﬁed time-points using a Leica SP8 microscope. Brieﬂy, mice were
anaesthetised and tumours were excited with an 880 nm pulsed Ti–Sapphire laser
and emitted light acquired at 440 nm (collagen second-harmonic generation, SHG)
and 530 nm (GFP). In addition, a mCherry signal was acquired sequentially using
confocal microscopy. During ~10-min intervals, 5 to 8 different regions were
imaged simultaneously for 2 h for each tumour. In each region, a z-stack of 4–5
images (approximately 50 µm deep on average) was taken at a spacing of 10 μm
between images, resulting in a time-lapse three-dimensional z-series for analysis.
To analyse the collagen content, mean intensity of SHG signal of the top
confocal plane for each z-stack was used. Moving cells were deﬁned as those that
moved 10 μm or more during the length of each movie.
RNA isolation and qRT-PCR. To obtain RNA from the different ﬁbroblast
populations, RNA was isolated using EZNA Total RNA Kit 1 (Omega Bio-tek).
Reverse transcription was performed using Precision NanoScript 2 Reverse-
Transcription-kit (PrimerDesign) and qPCR using PrecisionPLUS 2x qPCR Mas-
terMix with ROX and SybrGreen (PrimerDesign). Expression levels of indicated
genes were normalised to the expression of Gapdh, Rplp1 or Lamc2. Sequences of
the oligonucleotides used for qRT-PCR are described in the Supplementary
Table 5. For array analysis, RNA was isolated as described and processed in col-
laboration with Euroﬁns Genomics (GeneChip Mouse Gene 2.0 ST Array—details
available on reasonable request).
ChIP-qPCR. 7–10 × 106 NF or CAF at subconﬂuency were ﬁxed in 1% for-
maldehyde and sonicated using the Bioruptor Pico sonication device (Diagenode;
B01060001) using 15 cycles (30 s on; 30 s off) at maximum intensity. Puriﬁed
chromatin was then separated for: (i) immunoprecipitation using Dynabeads
Protein G (Life Technologies: 10003D) coated with 8 µg and 4 µg of HSF1 antibody
(ThermoFisher: RT-405-P, and Cell Signalling: 4356 S, respectively) per ChIP
experiment; (ii) non-immunoprecipitated chromatin, used as Input control; and
(iii) assessment of sonication efﬁciencies using a 1% agarose gel. For the quanti-
tative PCR brieﬂy, reactions were carried out in 10 μL volume containing 5 μL of
Sybergreen mix (Applied Biosystems; 4472918), 0.5 μL of primer (5 μM ﬁnal
concentration), 2.5 μL of genomic DNA and 2 μL of DNAse/RNAse-free water. A
three-step cycle programme and a melting analysis were applied. The cycling steps
were as follows: 10 s at 95 °C, 30 s at 60 °C and 30 s at 72 °C, for 40 cycles.
Enrichment of the immunoprecipitated sample was conﬁrmed using positive and
negative controls. The exact loci of the primers are as follows: negative control
(gene desert): chr6:116908976–116909177; Dkk3 Promoter (P):
chr7:112159485–112159638; Dkk3 Enhancer (E): chr7:112183116–112183344;
Rilpl, within the gene (positive control): chr5:124510011–124510190.
Gene expression analyses of clinical datasets. Gene expression analyses of
human tumour stroma were retrieved from NCBI Gene Expression Omnibus
(GEO). Datasets are described in Supplementary Figure 1a and include: Finak
(GSE9014, Breast), Karnoub (GSE8977, Breast), Yeoung (GSE40595, Ovary),
Nishida (GSE35602, Colon), Saadi (GSE19632, Aesophagus), Costea (GSE38517,
Oral SCC), Navab (GSE22863, Lung) and Sherman (GSE43770, Pancreas). Addi-
tional datasets include: GSE14548 (Breast cancer epithelia and stroma), GSE20086
(human breast NF and CAFs), GSE70468 (human colon NF and CAFs) and
GSE35250 (human ovarian NF and CAFs). In addition, the dataset describing the
expression proﬁles of cell populations puriﬁed from human colorectal cancer
(GSE39396) was also used. For Afﬁmetrix-based arrays, probe-to-gene mapping
was performed using Jetset43; for the rest of the arrays, highest variance probes
were selected. Probes mapping DKK genes used for each array can be found in
Supplementary Figure 1a. Unless otherwise stated, expression values for each gene
were z-score normalised. For the analyses of YAP/TAZ and β-catenin signatures in
tumour stromal datasets, we ﬁrst generated CAF-speciﬁc YAP/TAZ and β-catenin
signatures. Genes signiﬁcantly downregulated in murine CAF1 after transfection
with YAP/TAZ siRNA or XAV939 (β-catenin inhibitor) treatment were identiﬁed.
In addition, we sought for genes speciﬁcally expressed by FAP-positive CAFs in
human tumours using the GSE39396 dataset. This dataset describes the expression
proﬁles of cancer cells, immune cells, endothelial cells and CAFs puriﬁed from
human colorectal cancer. We identiﬁed genes signiﬁcantly upregulated more than
1.5-fold in FAP-positive samples when compared to the rest of the samples. Genes
from the YAP/TAZ and β-catenin signatures that overlapped with the genes in the
FAP-positive signature were selected into CAF-speciﬁc signatures; the rest were
selected into CAF-unspeciﬁc signatures. To calculate the gene-signature score in
each sample, we used single sample Gene Set Enrichment Analysis (ssGSEA)44
Projection Software from the GenePattern platform developed by the Broad
Institute of MIT and Harvard (USA) and available at GenePattern (www.
genepattern.broadinstitute.org), following the programs guidelines (log normal-
isation; weighting exponent 0.75). This analysis calculates separate enrichment
scores for each pairing of sample and gene set. Each ssGSEA enrichment score
represents the degree to which the genes in a particular gene set are co-ordinately
up- or downregulated within a sample. ssGSEA scores were z-score normalised. For
analyses of HSF1 signature, a similar approach was performed. The top 200 genes
downregulated between wild-type and Hsf1-null mouse embryonic ﬁbroblasts
(GSE56252) were identiﬁed and genes also present in the FAP-positive signature
were selected to generate the HSF1 CAF-speciﬁc signature.
Enrich database analysis. To identify putative transcription factors (TFs) reg-
ulating DKK3 expression we used the Enrich database14,15 [http://amp.pharm.
mssm.edu/Enrichr/]. We queried for DKK3 gene and retrieved the ChEA 2016
dataset to identify possible TFs that bind the DKK3 promoter, obtaining a list of 58
TFs (Supplementary Data 1). In addition, we retrieved the TF-LOF Expression from
GEO dataset to obtain a list of TFs whose loss of function has been associated to
changes in DKK3 expression (Supplementary Table 6).
Survival analyses. Analysis of clinical relevance of DKK3 expression was assessed
using publicly available data from the Kaplan–Meir Plotter platform for breast and
ovarian cancer45,46 (version 2014 and 2015, respectively), as well as the GSE17538
dataset for colorectal cancer47. Probe-to-gene mapping was performed using Jet-
set43. For survival analysis of ovarian cancer (progression-free survival), the highest
quartile of gene expression was used to dichotomise the different tumours into high
and low groups. Survival analyses for breast (recurrence-free survival) and colon
(disease-speciﬁc survival) datasets, tumours were split into high and low based on
median expression, respectively. For breast cancer, further analyses of recurrence-
free survival and distant-metastasis-free survival were performed based on ER-
status and molecular subtype. Breast cancer disease-free survival analysis based on
DKK3 expression in the tumour microenvironment was performed using the Finak
Dataset48. Only ER-negative patients were analysed. Mean DKK3 expression was
used to split tumours into high and low expression groups.
Gene-set enrichment analyses (GSEA). Array data were processed and analysed
using the Gene-set enrichment analysis software, developed by the Broad Institute
of MIT and Harvard (USA) and available at www.broadinstitute.org, following the
programme guidelines. The speciﬁc settings applied in all analyses are: Number of
Permutations (1000), Permutation Type (Gene set), Enrichment statistic (Weigh-
ted), and Metric for ranking genes (t Test). Values represent the False Discovery
Rate (-log2) and the Nominal Enrichment Score (NES) of each gene set. The list of
the speciﬁc gene sets analysed and their sources are available in Supplementary
Data 2.
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Statistical analyses. Statistical analyses were performed using GraphPad Prism
(GraphPad Software, Inc.). When n permitted, values were tested for Gaussian
distribution using the D’Agostino-Pearson normality test. For Gaussian distribu-
tions, paired or unpaired two-tailed Student’s t-test and one-way ANOVA with
Tukey post-test (for multiple comparisons) were performed. For non-Gaussian
distributions, Mann–Whitney’s test and Kruskal–Wallis test with Dunn’s post-test
(for multiple comparisons) were performed. Unless stated otherwise, mean values
and standard errors (SEM) are shown. Survival curves were estimated based on the
Kaplan–Meier method and compared using a log-rank test. P values of less than
0.05 were considered statistically signiﬁcant. Where indicated, individual p values
are shown; alternatively the following symbols were used to describe statistical
signiﬁcance: *P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.0001; n.s., non-signiﬁcant.
Reporting Summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Gene expression datasets of NF control or overexpressing DKK3, and CAF1 after
transfection with control or DKK3 siRNAs are available at the NCBI GEO under
GSE114056 [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114056].
The rest of the datasets generated and/or analysed during the current study are
available from the corresponding author upon reasonable request.
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